French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
On October 10, 2007, the company SENDAL France withdrew from the market lot H24746 of the medical device called TRANSFUSEND, manufactured by SENDAL SA, following the detection of a labeling error (11/10/2007) (14 ko ) concerning the CE marking of this device. This information is intended for pharmacists and local correspondents of materiovigilance for dissemination where appropriate to the services concerned.